Greenberg Traurig advised Gilde Healthcare, a specialist healthcare private equity fund, on its acquisition of EUROPIN Group, which is headquartered in Heidelberg, Germany. EUROPIN also has a development and production plant in Trenčín, Slovakia. EUROPIN specializes in the development and manufacturing of customized pen cannulas, lancet needles as well as cannulas for prefilled syringes and pharmaceutical applications. The parties agreed not to disclose the purchase price.
In 2021, Gilde Healthcare had acquired the cannula manufacturer Acti-Med AG, including a Polish subsidiary. According to the investor, the addition of EUROPIN thus represents a major step in forming a leading integrated contract manufacturer for cannulas and cannula systems. It is reported that both companies will operate separately under one roof while retaining both brands individually in the market.
The Greenberg Traurig team comprehensively advised Gilde Healthcare on all legal aspects of the transaction.
Background: Greenberg Traurig already advised the private equity fund on the acquisition of Acti-Med AG. The new instruction on the now completed add-on acquisition underlines the firm's strength in private equity transactions in the health care sector.
In 2021, Gilde Healthcare had acquired the cannula manufacturer Acti-Med AG, including a Polish subsidiary. According to the investor, the addition of EUROPIN thus represents a major step in forming a leading integrated contract manufacturer for cannulas and cannula systems. It is reported that both companies will operate separately under one roof while retaining both brands individually in the market.
The Greenberg Traurig team comprehensively advised Gilde Healthcare on all legal aspects of the transaction.
Background: Greenberg Traurig already advised the private equity fund on the acquisition of Acti-Med AG. The new instruction on the now completed add-on acquisition underlines the firm's strength in private equity transactions in the health care sector.